Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma.
Yamakawa N, Umeda M, Yoshii Y, Mitsudo K, Noguchi M, Kusukawa J, Katakura A, Nakayama H, Sasaki M, Noguchi T, Ueda M, Bukawa H, Yagihara K, Horie A, Miyazaki A, Chikazu D, Tomihara K, Mishima K, Otsuru M, Asoda S, Fujiwara S, Ohyama Y, Kurita H, Kawamata H, Fukuda M, Shintani Y, Kobayashi T, Kanno T, Oh-Iwa I, Kawano K, Yamashita Y, Kobayashi W, Ohiro Y, Uzawa K, Ota Y, Kirita T.
Yamakawa N, et al. Among authors: yamashita y.
Oral Dis. 2024 Mar;30(2):247-258. doi: 10.1111/odi.14471. Epub 2023 Jan 4.
Oral Dis. 2024.
PMID: 36519515